---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-002038"
form_type: "8-K"
ticker: "SENS"
cik: "0001616543"
company_name: "Senseonics Holdings, Inc."
filed_at: "2025-03-03T23:59:59+00:00"
generated_at: "2026-05-25T17:49:46.365871+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Senseonics Q4 revenue $8.3M, net loss $15.5M; guides FY25 revenue $34-38M

## Summary
- Q4 revenue $8.3M (up from $8.0M YoY); net loss $15.5M ($0.02 loss per share).
- Full-year 2024 revenue $22.5M (flat YoY); net loss $78.6M ($0.12 loss per share).
- Patient base grew 56% in 2024 to ~6,000 global patients; Eversense 365 FDA approved and launched.
- FY2025 guidance: revenue $34-38M, gross margins 25-30%, cash usage $50-60M.
- Post-quarter: raised ~$27M via ATM, repaid $20.4M convertible notes; debt reduced to $35M.

## SEC filing metadata
- accession: 0001558370-25-002038
- form_type: 8-K
- ticker: SENS
- cik: 0001616543
- company_name: Senseonics Holdings, Inc.
- filed_at: 2025-03-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1616543/000155837025002038/0001558370-25-002038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1616543/000155837025002038/sens-20250303x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-002038
- JSON: https://secwatch.observer/filing/0001558370-25-002038.json
- Plain text: https://secwatch.observer/filing/0001558370-25-002038.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.